Ignite Creation Date:
2024-05-06 @ 12:58 PM
Last Modification Date:
2024-10-26 @ 1:06 PM
Study NCT ID:
NCT03893071
Status:
UNKNOWN
Last Update Posted:
2021-06-18
First Post:
2019-02-20
Brief Title:
Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo HPβCD in Niemann-Pick Disease Type C
Sponsor:
Cyclo Therapeutics Inc
Organization:
Cyclo Therapeutics Inc
Organization Data
Organization:
Cyclo Therapeutics Inc
Class:
INDUSTRY
Study ID:
CTD-TCNPC-102
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cyclo Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None